High Agreement between Barrett Universal II Calculations with and without Utilization of Optional Biometry Parameters

por Vega, Yakov, Gershoni, Assaf, Achiron, Asaf, Tuuminen, Raimo, Weinberger, Yehonatan, Livny, Eitan, Nahum, Yoav, Bahar, Irit, Elbaz, Uri
Publicado 2021

Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction

por Livnat, Tami, Weinberger, Yehonatan, Fernández, José A., Bashir, Alaa, Ben-David, Gil, Palevski, Dahlia, Levy-Mendelovich, Sarina, Kenet, Gili, Budnik, Ivan, Nisgav, Yael, Griffin, John H., Weinberger, Dov
Publicado 2021

3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina

por Weinberger, Yehonatan, Budnik, Ivan, Nisgav, Yael, Palevski, Dahlia, Ben-David, Gil, Fernández, José A., Margalit, Shany Nivinsky, Levy-Mendelovich, Sarina, Kenet, Gili, Weinberger, Dov, Griffin, John H., Livnat, Tami
Publicado 2023

3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation

por Palevski, Dahlia, Ben-David, Gil, Weinberger, Yehonatan, Haj Daood, Rabeei, Fernández, José A., Budnik, Ivan, Levy-Mendelovich, Sarina, Kenet, Gili, Nisgav, Yael, Weinberger, Dov, Griffin, John H., Livnat, Tami
Publicado 2022